Investing.com - TD Cowen raised its price target on Royalty Pharma shares (NASDAQ:RPRX) to $50 from $45 while maintaining a Buy rating on the stock. The shares currently trade at $46.06, up 27% over ...

TD Cowen raised the firm’s price target on Butterfly Network (BFLY) to $6 from $4.50 and keeps a Buy rating on the shares. The firm said they reported strng Q4 results and Butterfly Embedded should ...

Royalty Pharma Plc (NASDAQ:RPRX) is one of the best cheap biotech stocks to buy now. TD Cowen lifted the price target on Royalty Pharma Plc (NASDAQ:RPRX) to $50 from $45 on February 27, maintaining a ...

Visit the official source for NFL News, NFL schedules, stats, scores and more. Get all the latest NFL Football news now!

With close to a decade of writing and editing experience, Maisha specializes in service journalism and has produced work in the lifestyle, financial services, real estate, and culture spaces. She uses ...